×
Use of Antipsychotics in the Treatment of Major Depressive Disorder in the U.S. Department of Veterans Affairs PDF
$ 40.00
Use of Antipsychotics in the Treatment of Major Depressive Disorder in the U.S. Department of Veterans Affairs PDF quantity
$ 40.00
×
Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics PDF
$ 40.00
Number Needed to Treat to Harm for Discontinuation Due to Adverse Events in the Treatment of Bipolar Depression, Major Depressive Disorder, and Generalized Anxiety Disorder With Atypical Antipsychotics PDF quantity
$ 40.00
×
Quality of Life Following Remission of Mental Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions PDF
$ 40.00
Quality of Life Following Remission of Mental Disorders: Findings From the National Epidemiologic Survey on Alcohol and Related Conditions PDF quantity
$ 40.00
×
On the Threshold of Disorder: A Study of the Impact of the DSM-IV Clinical Significance Criterion on Diagnosing Depressive and Anxiety Disorders in Clinical Practice. PDF
$ 40.00
On the Threshold of Disorder: A Study of the Impact of the DSM-IV Clinical Significance Criterion on Diagnosing Depressive and Anxiety Disorders in Clinical Practice. PDF quantity
$ 40.00
×
Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs PDF
$ 40.00
Association of Obesity and Inflammatory Marker Levels on Treatment Outcome: Results From a Double-Blind, Randomized Study of Adjuncve L-Methylfolate Calciumin Paents With MDD Who Are Inadequate Responders to SSRIs PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
